144 related articles for article (PubMed ID: 21344373)
1. Direct anti-cancer effect of oncostatin M on chondrosarcoma.
David E; Guihard P; Brounais B; Riet A; Charrier C; Battaglia S; Gouin F; Ponsolle S; Bot RL; Richards CD; Heymann D; Rédini F; Blanchard F
Int J Cancer; 2011 Apr; 128(8):1822-35. PubMed ID: 21344373
[TBL] [Abstract][Full Text] [Related]
2. Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells.
Brounais B; David E; Chipoy C; Trichet V; Ferré V; Charrier C; Duplomb L; Berreur M; Rédini F; Heymann D; Blanchard F
Bone; 2009 May; 44(5):830-9. PubMed ID: 19168167
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of Midostaurin in vivo.
Brounais B; Chipoy C; Mori K; Charrier C; Battaglia S; Pilet P; Richards CD; Heymann D; Rédini F; Blanchard F
Clin Cancer Res; 2008 Sep; 14(17):5400-9. PubMed ID: 18765531
[TBL] [Abstract][Full Text] [Related]
6. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
Front Immunol; 2019; 10():1164. PubMed ID: 31191537
[No Abstract] [Full Text] [Related]
7. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of matrilin-3 not only in osteoarthritic articular cartilage but also in cartilage-forming tumors, and down-regulation of SOX9 via epidermal growth factor domain 1-dependent signaling.
Vincourt JB; Vignaud JM; Lionneton F; Sirveaux F; Kawaki H; Marchal S; Lomazzi S; Plénat F; Guillemin F; Netter P; Takigawa M; Mainard D; Magdalou J
Arthritis Rheum; 2008 Sep; 58(9):2798-808. PubMed ID: 18759284
[TBL] [Abstract][Full Text] [Related]
9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
10. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
Chen SH; Gillespie GY; Benveniste EN
Glia; 2006 Jan; 53(2):191-200. PubMed ID: 16206166
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
Matthews VB; Knight B; Tirnitz-Parker JE; Boon J; Olynyk JK; Yeoh GC
Exp Cell Res; 2005 May; 306(1):252-63. PubMed ID: 15878349
[TBL] [Abstract][Full Text] [Related]
13. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; Fiselier TJ; Franssen MJ; Joosten LA; Van Lent PL; Richards CD; van den Berg WB
Arthritis Rheum; 2003 Jun; 48(6):1750-61. PubMed ID: 12794844
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
[TBL] [Abstract][Full Text] [Related]
16. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
Hui W; Rowan AD; Richards CD; Cawston TE
Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
[TBL] [Abstract][Full Text] [Related]
18. Novel function of Oncostatin M as a potent tumour-promoting agent in lung.
Lauber S; Wong S; Cutz JC; Tanaka M; Barra N; Lhoták S; Ashkar A; Richards CD
Int J Cancer; 2015 Feb; 136(4):831-43. PubMed ID: 24976180
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin m, an inflammatory cytokine produced by macrophages, supports intramembranous bone healing in a mouse model of tibia injury.
Guihard P; Boutet MA; Brounais-Le Royer B; Gamblin AL; Amiaud J; Renaud A; Berreur M; Rédini F; Heymann D; Layrolle P; Blanchard F
Am J Pathol; 2015 Mar; 185(3):765-75. PubMed ID: 25559270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
